2010
Cost evaluation of evidence-based treatments.
Sindelar JL, Ball SA. Cost evaluation of evidence-based treatments. Addiction Science & Clinical Practice 2010, 5: 44-51. PMID: 22002453, PMCID: PMC3120119.Peer-Reviewed Original Research
2007
Treatment programs in the National Drug Abuse Treatment Clinical Trials Network
McCarty D, Fuller B, Kaskutas LA, Wendt WW, Nunes EV, Miller M, Forman R, Magruder KM, Arfken C, Copersino M, Floyd A, Sindelar J, Edmundson E. Treatment programs in the National Drug Abuse Treatment Clinical Trials Network. Drug And Alcohol Dependence 2007, 92: 200-207. PMID: 17875368, PMCID: PMC2223274, DOI: 10.1016/j.drugalcdep.2007.08.004.Peer-Reviewed Original ResearchMeSH KeywordsAccreditationAlcoholismAnalysis of VarianceConfidentialityData Interpretation, StatisticalHealth Care SurveysHeroin DependenceHumansMethadoneModels, OrganizationalNarcoticsPhilosophy, MedicalQuality Assurance, Health CareResidential TreatmentSubstance Abuse Treatment CentersSubstance-Related DisordersUnited StatesWorkforceConceptsClinical Trials NetworkNational Drug Abuse Treatment Clinical Trials NetworkDrug disordersCommunity-based treatment organizationsTreatment programTrials NetworkSubstance abuse treatment servicesPatient drug useInpatient treatment unitMental health clinicsLevel of careDrug abuse treatment programsCo-occurring conditionsSelf-help meetingsPatient demographicsHealth clinicsTreatment centersTreatment servicesDrug useTreatment philosophyMedical settingsTreatment organizationsVocational servicesNational surveyUniversity-based research centerCost‐effectiveness of prize‐based contingency management in methadone maintenance treatment programs
Sindelar JL, Olmstead TA, Peirce JM. Cost‐effectiveness of prize‐based contingency management in methadone maintenance treatment programs. Addiction 2007, 102: 1463-1471. PMID: 17645428, PMCID: PMC3072844, DOI: 10.1111/j.1360-0443.2007.01913.x.Peer-Reviewed Original ResearchConceptsPrize-based contingency managementUsual careContingency managementStimulant-negative urine samplesUrine samplesNational Drug Abuse Treatment Clinical Trials NetworkTreatment programMethadone maintenance treatment programIncremental costBaseline urine samplesMulti-site clinical trialMaintenance treatment programMethadone maintenance clinicsClinical Trials NetworkCommunity treatment programsCost-effectiveness studiesCost of treatmentCost-effectiveness analysisPresence of stimulantsCM conditionClinical trialsCommunity clinicsMaintenance clinicsEffectiveness trialTreatment outcomes
2006
Cost-effectiveness of prize-based incentives for stimulant abusers in outpatient psychosocial treatment programs
Olmstead TA, Sindelar JL, Petry NM. Cost-effectiveness of prize-based incentives for stimulant abusers in outpatient psychosocial treatment programs. Drug And Alcohol Dependence 2006, 87: 175-182. PMID: 16971054, PMCID: PMC1950254, DOI: 10.1016/j.drugalcdep.2006.08.012.Peer-Reviewed Original ResearchConceptsUsual careStimulant abusersClinical trialsPatient outcomesNational Drug Abuse Treatment Clinical Trials NetworkDrug abuse treatment clinicsAbstinence-based incentivesIncremental cost-effectiveness ratioUsual care groupPrimary patient outcomeRandomized clinical trialsClinical Trials NetworkPsychosocial treatment programCost-effectiveness ratioCost-effectiveness analysisCare groupTreatment clinicsStimulant abstinenceAcceptability curvesAbstinence timeTreatment programTrials NetworkIncremental costCareIncentive group
2005
The role of depression symptoms in predicting drug abstinence in outpatient substance abuse treatment
Dodge R, Sindelar J, Sinha R. The role of depression symptoms in predicting drug abstinence in outpatient substance abuse treatment. Journal Of Substance Use And Addiction Treatment 2005, 28: 189-196. PMID: 15780549, DOI: 10.1016/j.jsat.2004.12.005.Peer-Reviewed Original ResearchMeSH KeywordsAdultAmbulatory CareComorbidityConnecticutCross-Sectional StudiesDepressionFemaleFinancing, GovernmentHumansMaleMiddle AgedMotivationPatient CompliancePatient DischargePublic AssistanceRegression AnalysisSecondary PreventionSocioeconomic FactorsSubstance Abuse DetectionSubstance-Related DisordersTreatment OutcomeConceptsLength of staySubstance abuse treatment outcomesOutpatient substance abuse treatmentSubstance abuse treatmentDepressive symptomsInsurance statusTreatment outcomesAbstinence statusDepression symptomsDrug useDrug abstinenceAbuse treatmentReal-world clinical settingHigher depressive symptom scoresOutpatient substance abuse treatment programsDepressive symptom scoresSubstance abuse treatment programsSymptom scoresTreatment characteristicsPrimary drugDecreased likelihoodReferral sourceClinical settingSymptomsTreatment program
2004
To what extent are key services offered in treatment programs for special populations?
Olmstead T, Sindelar JL. To what extent are key services offered in treatment programs for special populations? Journal Of Substance Use And Addiction Treatment 2004, 27: 9-15. PMID: 15223088, DOI: 10.1016/j.jsat.2004.03.004.Peer-Reviewed Original Research
2001
INNOVATIONS IN TREATMENT FOR DRUG ABUSE: Solutions to a Public Health Problem
Sindelar J, Fiellin D. INNOVATIONS IN TREATMENT FOR DRUG ABUSE: Solutions to a Public Health Problem. Annual Review Of Public Health 2001, 22: 249-272. PMID: 11274521, DOI: 10.1146/annurev.publhealth.22.1.249.ChaptersConceptsPublic health problemEffectiveness of treatmentIllicit drug useDrug useHealth problemsDrug dependenceBroader social costsImportant public health problemNew pharmacological agentsFuture treatment programsIndividual functioningStandard treatmentPharmacological agentsTreatment programDrug abuseCounseling strategiesPrevention effortsHigh dropout rateTreatmentFunctioningCompletion ratesDropout rateLow completion ratesLow effectivenessNew setting